The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 18, 2025
Filed:
Dec. 03, 2024
Applicant:
Poviva Corp, Carson City, NV (US);
Inventors:
John Docherty, Port Perry, CA;
Christopher Andrew Bunka, Kelowna, CA;
Assignee:
POVIVA CORP, Carson City, NV (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); A61K 9/48 (2006.01); A61K 47/02 (2006.01); A61K 47/26 (2006.01); A61K 47/28 (2006.01); A61K 47/44 (2017.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4875 (2013.01); A61K 47/02 (2013.01); A61K 47/26 (2013.01); A61K 47/28 (2013.01); A61K 47/44 (2013.01); A61P 3/10 (2018.01);
Abstract
Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.